eprintid: 10120524
rev_number: 17
eprint_status: archive
userid: 608
dir: disk0/10/12/05/24
datestamp: 2021-02-03 16:10:37
lastmod: 2022-04-20 17:06:11
status_changed: 2021-02-03 16:10:37
type: article
metadata_visibility: show
creators_name: Carli, S
creators_name: Chaabane, L
creators_name: Butti, C
creators_name: De Palma, C
creators_name: Aimar, P
creators_name: Salio, C
creators_name: Vignoli, A
creators_name: Giustetto, M
creators_name: Landsberger, N
creators_name: Frasca, A
title: In vivo magnetic resonance spectroscopy in the brain of Cdkl5 null mice reveals a metabolic profile indicative of mitochondrial dysfunctions
ispublished: pub
divisions: UCL
divisions: B02
divisions: C10
divisions: D17
divisions: G95
keywords: 5’-AMP-activated protein kinase, CDKL5 deficiency disorder (CDD), Cdkl5 mouse model, MRI/MRS studies, biomarkers, mitochondria
note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
abstract: Mutations in the X‐linked CDKL5 gene cause CDKL5 deficiency disorder (CDD), a severe neurodevelopmental condition mainly characterized by infantile epileptic encephalopathy, intellectual disability, and autistic features. The molecular mechanisms underlying the clinical symptoms remain largely unknown and the identification of reliable biomarkers in animal models will certainly contribute to increase our comprehension of CDD as well as to assess the efficacy of therapeutic strategies. Here, we used different Magnetic Resonance (MR) methods to disclose structural, functional, or metabolic signatures of Cdkl5 deficiency in the brain of adult mice. We found that loss of Cdkl5 does not cause cerebral atrophy but affects distinct brain areas, particularly the hippocampus. By in vivo proton‐MR spectroscopy (MRS), we revealed in the Cdkl5 null brain a metabolic dysregulation indicative of mitochondrial dysfunctions. Accordingly, we unveiled a significant reduction in ATP levels and a decrease in the expression of complex IV of mitochondrial electron transport chain. Conversely, the number of mitochondria appeared preserved. Importantly, we reported a significant defect in the activation of one of the major regulators of cellular energy balance, the adenosine monophosphate‐activated protein kinase (AMPK), that might contribute to the observed metabolic impairment and become an interesting therapeutic target for future preclinical trials. In conclusion, MRS revealed in the Cdkl5 null brain the presence of a metabolic dysregulation suggestive of a mitochondrial dysfunction that permitted to foster our comprehension of Cdkl5 deficiency and brought our interest towards targeting mitochondria as therapeutic strategy for CDD.
date: 2021-05
date_type: published
official_url: https://doi.org/10.1111/jnc.15300
oa_status: green
full_text_type: other
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 1843971
doi: 10.1111/jnc.15300
lyricists_name: Butti, Clarissa
lyricists_id: CBUTT82
actors_name: Flynn, Bernadette
actors_id: BFFLY94
actors_role: owner
full_text_status: public
publication: Journal of Neurochemistry
volume: 157
number: 4
pagerange: 1253-1269
event_location: England
citation:        Carli, S;    Chaabane, L;    Butti, C;    De Palma, C;    Aimar, P;    Salio, C;    Vignoli, A;             ... Frasca, A; + view all <#>        Carli, S;  Chaabane, L;  Butti, C;  De Palma, C;  Aimar, P;  Salio, C;  Vignoli, A;  Giustetto, M;  Landsberger, N;  Frasca, A;   - view fewer <#>    (2021)    In vivo magnetic resonance spectroscopy in the brain of Cdkl5 null mice reveals a metabolic profile indicative of mitochondrial dysfunctions.                   Journal of Neurochemistry , 157  (4)   pp. 1253-1269.    10.1111/jnc.15300 <https://doi.org/10.1111/jnc.15300>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10120524/1/jnc.15300.pdf